Nursing Review Issue 04 Jul - Aug 2020 | Page 24

clinical practice Trials and tribulations Can a reliable COVID-19 vaccine be developed as soon as we’d like? David Paterson interviewed by Conor Burke A lot has been said about how we might get out of this pandemic and back to some semblance of normality. Many people, including some of our experts and top politicians, have said that a full return to our old way of life will only happen when a vaccine is discovered. Some experts initially said a year to 18 months was achievable, but is that really likely? It took 28 years to find vaccines for the flu and chicken pox and researchers don’t expect to see an HIV vaccine readily available until 2030, that’s 50 years after the initial outbreak. Add to that the fact that we also haven’t found vaccines for other forms of coronavirus, and our odds seem somewhat bleak. But there are experts around the world working on solutions, including the use of existing drugs for treatment of COVID-19. Professor David Paterson, the director of the University of Queensland Centre for Clinical Research, is one of those researchers and he is involved in clinical trials of existing drugs on patients in Queensland hospitals. 22 | nursingreview.com.au Patterson spoke with Nursing review in May about the trials and the race for a coronavirus cure. NR: What is the state of play in regards to a cure or treatment for this coronavirus as you see it? DP: While we’re all on the edge of our seats wondering when we are going to get back to normal, the bad news is that it’s certainly not going to be in 2020, I think, in terms of finding a very effective treatment or a vaccine. I think we’re going to be waiting until 2021 or even beyond. It’s important to differentiate treatments and vaccines. I guess it’s probably better to get rid of the terminology ‘cure’, because that’s something we don’t really use much in medicine and I think it clouds the issue really. Typically we’ve said for viral infections that we don’t have many effective treatments, unlike bacterial infections for which we have antibiotics. There’s no doubt that there are many infections that are due to bacteria, and if we give an antibiotic, we can get rid of those bacteria and a person’s symptoms completely resolve and they get on with their life. But there’s not really many antivirals that truly do completely eradicate an infection, and without a risk of the infection reoccurring or, in the situation with HIV, for example, where we can truly say that we’ve got rid of the virus because we know, of course, if a person who is on an anti-HIV drug stopped their medications it would come back. With coronavirus we’ve got two things happening. One is the virus itself, and the other is the body’s immune response to that viral infection. You might say, “Well, the body’s immune response is surely only going to be a positive thing. It’s going to help get rid of the viral infection.” But we find in many viruses, including this novel coronavirus, that the immune response sometimes goes overboard and that is certainly a contributor to some of the problems that people develop. First of all, we would evaluate whether there are drugs that we can use to kill the virus. What we’ve heard a lot about in the news recently is remdesivir, which is a drug that was developed to treat Ebola, and which has some activity against the novel coronavirus. We’ve heard leaked reports, we’ve heard little snippets from the results of trials, but we don’t really know how well this drug works. It certainly doesn’t appear to be something that it works universally, and